ERYtech Pharma Reports Financial Highlights For Q3 2015

LYON, France--(BUSINESS WIRE)--Regulatory News:

ERYTECH ended the third quarter of 2015 with a total net cash position, including short term treasury investments, of € 28.2 million, compared to total net cash position of € 31.0 million at the end of the second quarter of 2015. The total net use of cash amounted to € 2.8 million for the third quarter of 2015, compared to € 3.4 million in the second quarter of 2015.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC